Abstract
Purpose
To report a case of macular edema after the use of the oral hypoglycemic agent rosiglitazone.
Methods
A 43-year-old man, who had diabetic mellitus and was on oral rosiglitazone therapy, complained of a visual disturbance in his left eye. After fundus examination and optical coherence tomography, macular edema was observed, therefore rosiglitazone therapy was discontinued.
References
1. Stumvoll M, Hfaring HU. Glitazones: clinical effects and molecular mechanisms. Ann Med. 2002; 34:217–24.
2. Mudaliar S, Chang AR, Henry RR. Thiazolidinediones, peripheral edema, and type 2 diabetes: incidence, pathophysiology, and clinical implications. Endocr Pract. 2003; 9:406–16.
4. Kennedy F. Do thiazolidinediones cause congestive heart failure? Mayo Clin Proc. 2003; 78:1088–91.
5. Kermani A, Garg A. Thiazolidinedione-associated congestive heart failure and pulmonary edema. Mayo Clin Proc. 2003; 78:1088–91.
6. Wang CH, Weisel RD, Liu PP, et al. Glitazones and heart failure: critical appraisal for the clinician. Circulation. 2003; 107:1350–4.
7. Coluciello M. Vision loss due to macular edema induced by rosiglitazone treatment of diabetes mellitus. Arch Ophthalmol. 2005; 123:1273–5.
9. Ryan EH, Han DP, Ramsay RC, et al. Diabetic macular edema associated with glitazone use. Retina. 2006; 26:562–70.
10. Graham DJ, Green L, Senior JR, et al. Troglitazone induced liver failure: a case study. Am J Med. 2003; 114:299–306.
11. Bresnick GH. Diabetic macular edema. A review. Ophthalmology. 1986; 93:989–97.